Taiwan's Jyong Biotech to establish new manufacturing facility and US operations centre in Texas

Jyong Biotech, a Taiwan-based science-driven biotechnology company dedicated to the development and commercialisation of...

October 17, 2026 | Saturday | News
AtomVie inks strategic partnership with Jubilant Radiopharma to strengthen logistics and distribution in Clinical Trials

AtomVie Global Radiopharma, a global contract developer and manufacturer (CDMO) for radiopharmaceuticals, has announced ...

October 16, 2026 | Friday | News
Charles River collaborates with Magellan Stem Cells to advance regenerative medicine development

Charles River Laboratories International, Inc. and Magellan Stem Cells, a private Australian biotech and cell-therapy fi...

October 16, 2026 | Friday | News
China's Brii Biosciences unveils BRiSC™, an siRNA Therapeutics discovery platform

Brii Biosciences, a China-based biotechnology company developing therapies to improve patient health and choice across d...

October 16, 2026 | Friday | News
Japan's JCR Pharma receives marketing authorisation in Kuwait for Enzyme Replacement Therapy to treat Hunter Syndrome

Japan-based JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies...

October 15, 2026 | Thursday | News
The Future of FTIR Microscopy Lies in Smarter, Faster and More Precise Chemical Analysis

As laboratories across Asia-Pacific face growing demands for faster, more precise and reproducible analytical testing, F...

October 15, 2026 | Thursday | Opinion
Swiss firm Alentis Therapeutics partners with Korea's PinotBio to develop next-gen ADCs targeting claudin-1

Swiss firm Alentis Therapeutics and South Korea based PinotBio have entered into a research collaboration and licensing ...

October 15, 2026 | Thursday | News
New Sydney laboratory expands 360biolabs’ Australian network

360biolabs, a BioAgilytix company, has opened a new laboratory in Sydney, bringing its established bioanalytical experti...

October 15, 2026 | Thursday | News
Beyond Patent Expiry: Rethinking the Future of Mature Medicines in Asia-Pacific

As pharmaceutical innovation accelerates, mature medicines remain essential to healthcare systems, y...

October 14, 2026 | Wednesday | Opinion
Waters launches AI Link for advancing AI-enabled LC-MS workflows from research to release

US-based Waters Corporation has launched Waters AI Link, a software capability that brings Anthropic's Model Context Pro...

October 14, 2026 | Wednesday | News
Asieris Pharma partners with Theramex for global development of non-surgical treatment for cervical precancerous lesions in ANZ

Theramex, a London-headquartered specialty pharmaceutical company dedicated to women and their health, and China-based A...

October 13, 2026 | Tuesday | News
Roche inks $1.06 B deal with China's Rona Therapeutics for RNA-based metabolic therapies

Chinese startup Rona Therapeutics has granted Roche an exclusive worldwide license for Rona's investigational RNAi candi...

October 14, 2026 | Wednesday | News
Korea's NTL HEALTHCARE announces global launch of On-Premises AI Solution 'CerviCARE® AI AT'

South Korea-based NTL HEALTHCARE, a women's health AI company, has announced the global launch of CerviCARE® AI AT, ...

October 16, 2026 | Friday | News
Americhem opens new clean compounding facility in Suzhou, China

Americhem, a global leader in custom polymer solutions, recently celebrated the opening of its new clean compounding fac...

October 13, 2026 | Tuesday | News
ITOCHU Corp signs capital alliance agreement with MOLCURE Inc. for AI-based drug discovery in Japan

ITOCHU Corporation has signed a capital alliance agreement with MOLCURE Inc., which possesses AI-driven drug discovery t...

October 14, 2026 | Wednesday | News
Australia's Firebrick Pharma secures $732k in strategic investments

Australia-based Firebrick Pharma has secured firm commitments from strategic investors for approximately $732k, through ...

October 12, 2026 | Monday | News
Ono Pharma inks $100 M agreement with Biohaven to develop and commercialise IgG degraders in Japan, South Korea, Taiwan, and ASEAN countries

Japan-based Ono Pharmaceutical has entered into an exclusive license agreement with Biohaven, together with its wholly o...

October 12, 2026 | Monday | News
Korea's Lunit collaborates with US-based Discovery Life Sciences to expand AI-powered tissue analysis for biopharma research

South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced a strateg...

October 12, 2026 | Monday | News
Foresee Pharma announces China NMPA approval of CAMCEVI® 42 mg for treatment of advanced prostate cancer

Taiwan-based Foresee Pharmaceuticals has been notified by its licensing partner, Changchun GeneScience Pharmaceutical (G...

October 12, 2026 | Monday | News
Japan's Shimadzu initiates validation of mass spec solution for core labs in Australia

Japan-based Shimadzu Corporation has started the development and validation of a mass spectrometry (MS) solution for cor...

October 9, 2026 | Friday | News
Danaher accelerates Life Sciences research with new AI-powered autonomous lab

US-based Danaher Corporation has announced plans to launch its first AI-powered autonomous lab, designed to help researc...

October 9, 2026 | Friday | News
Korea's LOTTE Biologics inks US-based manufacturing agreement with Alvotech to increase global supply

South Korea-based LOTTE Biologics, a contract development and manufacturing (CDMO) organisation, and Alvotech, a global ...

October 9, 2026 | Friday | News
GE HealthCare buys SOFIE Biosciences for $945 M to establish 'Final Mile' footprint for PET Radiopharmaceutical Supply in US

GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a leading US-based CMO for PET radiopha...

October 8, 2026 | Thursday | News
Japan's Third Way: BioJapan Day 2 Maps the Routes Out and the Reasons to Come In

If the opening day of BioJapan 2026 diagnosed the gap between Japanese science and global deals, the second day at PACIF...

October 8, 2026 | Thursday | News
China's XtalPi debuts Kodexia™ as world's first closed-loop siRNA platform

China's XtalPi Holdings, an AI and robotics-driven drug and materials discovery company, has debuted Kodexia™, the...

October 8, 2026 | Thursday | News